{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:14:56Z","timestamp":1791324896530,"version":"4.3.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302183"],"award-info":[{"award-number":["82302183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471935"],"award-info":[{"award-number":["82471935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271934"],"award-info":[{"award-number":["82271934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yangfan Project of Science and Technology Commission of Shanghai Municipality","award":["22YF1442400"],"award-info":[{"award-number":["22YF1442400"]}]},{"name":"Research Found of Health Commission of Changing District, Shanghai Municipality","award":["2023QN01"],"award-info":[{"award-number":["2023QN01"]}]},{"name":"Laboratory Open Fund of Key Technology and Materials in Minimally Invasive Spine Surgery","award":["2024JZWC-ZDA03"],"award-info":[{"award-number":["2024JZWC-ZDA03"]}]},{"name":"Laboratory Open Fund of Key Technology and Materials in Minimally Invasive Spine Surgery","award":["2024JZWC-YBA07"],"award-info":[{"award-number":["2024JZWC-YBA07"]}]},{"name":"Research Fund of Tongren Hospital, Shanghai Jiao Tong University School of Medicine","award":["TRKYRC-XX202204"],"award-info":[{"award-number":["TRKYRC-XX202204"]}]},{"name":"Research Fund of Tongren Hospital, Shanghai Jiao Tong University School of Medicine","award":["TRYJ2021JC06"],"award-info":[{"award-number":["TRYJ2021JC06"]}]},{"name":"Research Fund of Tongren Hospital, Shanghai Jiao Tong University School of Medicine","award":["TRGG202101"],"award-info":[{"award-number":["TRGG202101"]}]},{"name":"Research Fund of Tongren Hospital, Shanghai Jiao Tong University School of Medicine","award":["TRYXJH18"],"award-info":[{"award-number":["TRYXJH18"]}]},{"name":"Research Fund of Tongren Hospital, Shanghai Jiao Tong University School of Medicine","award":["TRYXJH28"],"award-info":[{"award-number":["TRYXJH28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To review the evidence for clinical adoption of clear cell likelihood score (ccLS) for identifying clear cell renal cell carcinoma (ccRCC) from small renal masses (SRMs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We distinguished the literature on ccLS for identifying ccRCC via systematic search using PubMed, Embase, Web of Science, China National Knowledge Infrastructure, and Wanfang Data until 31 March, 2024. The risk of bias and concern on application was assessed using the modified quality assessment of diagnostic accuracy studies (QUADAS-2) tool. The level of evidence supporting the clinical adoption of ccLS for identifying ccRCC was determined based on meta-analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight MRI studies and three CT studies were included. The risk of bias and application were mainly related to the index test and flow and timing, due to incomplete imaging protocol, unclear rating process, and inappropriate interval between imaging and surgery. The diagnostic odds ratios (95% confidence intervals) of MRI and CT ccLS were 14.69 (9.71\u201322.22; 6 studies, 1429 SRM, 869 ccRCC), and 5.64 (3.34\u20139.54; 3 studies, 296 SRM, 147 ccRCC), respectively, for identifying ccRCC from SRM. The evidence level for clinical adoption of MRI and CT ccLS were both rated as weak. MRI ccLS version 2.0 potentially has better diagnostic performance than version 1.0 (1 study, 700 SRM, 509 ccRCC). Both T2-weighted-imaging with or without fat suppression might be suitable for MRI ccLS version 2.0 (1 study, 111 SRM, 82 ccRCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ccLS shows promising diagnostic performance for identifying ccRCC from SRM, but the evidence for its adoption in clinical routine remains weak.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevance statement<\/jats:title>\n                <jats:p>Although clear cell likelihood score (ccLS) demonstrates promising performance for detecting clear cell renal cell carcinoma, additional evidence is crucial to support its routine use as a tool for both initial diagnosis and active surveillance of small renal masses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Clear cell likelihood score is designed for the evaluation of small renal masses.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Both CT and MRI clear cell likelihood scores are accurate and efficient.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>More evidence is necessary for the clinical adoption of a clear cell likelihood score.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-024-01829-y","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:02:21Z","timestamp":1728478941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is there enough evidence supporting the clinical adoption of clear cell likelihood score (ccLS)? An updated systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Jingyu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minda","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-8520","authenticated-orcid":false,"given":"Weiwu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.juro.2006.04.047","volume":"176","author":"M Remzi","year":"2006","unstructured":"Remzi M, Ozsoy M, Klingler HC et al (2006) Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176:896\u2013899. https:\/\/doi.org\/10.1016\/j.juro.2006.04.047","journal-title":"J Urol"},{"key":"1829_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.juro.2007.03.129","volume":"178","author":"S Pahernik","year":"2007","unstructured":"Pahernik S, Ziegler S, Roos F, Melchior SW, Th\u00fcroff JW (2007) Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 178:414\u2013417. https:\/\/doi.org\/10.1016\/j.juro.2007.03.129","journal-title":"J Urol"},{"key":"1829_CR3","doi-asserted-by":"publisher","first-page":"g4797","DOI":"10.1136\/bmj.g4797","volume":"349","author":"E Jonasch","year":"2014","unstructured":"Jonasch E, Gao J, Rathmell WK (2014) Renal cell carcinoma. BMJ 349:g4797. https:\/\/doi.org\/10.1136\/bmj.g4797","journal-title":"BMJ"},{"key":"1829_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1148\/radiol.2019182646","volume":"292","author":"SG Silverman","year":"2019","unstructured":"Silverman SG, Pedrosa I, Ellis JH et al (2019) Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology 292:475\u2013488. https:\/\/doi.org\/10.1148\/radiol.2019182646","journal-title":"Radiology"},{"key":"1829_CR5","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1016\/j.jacr.2020.09.010","volume":"17","author":"ZJ Wang","year":"2020","unstructured":"Expert Panel on Urologic Imaging, Wang ZJ, Nikolaidis P et al (2020) ACR appropriateness criteria\u00ae indeterminate renal mass. J Am Coll Radiol 17:S415\u2013S428. https:\/\/doi.org\/10.1016\/j.jacr.2020.09.010","journal-title":"J Am Coll Radiol"},{"key":"1829_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.eururo.2022.01.040","volume":"81","author":"E Roussel","year":"2022","unstructured":"Roussel E, Capitanio U, Kutikov A et al (2022) Novel imaging methods for renal mass characterization: a collaborative review. Eur Urol 81:476\u2013488. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.040","journal-title":"Eur Urol"},{"key":"1829_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1089\/end.2013.0724","volume":"28","author":"MP Laguna","year":"2014","unstructured":"Laguna MP, Algaba F, Cadeddu J et al (2014) Current patterns of presentation and treatment of renal masses: a clinical research office of the endourological society prospective study. J Endourol 28:861\u2013870. https:\/\/doi.org\/10.1089\/end.2013.0724","journal-title":"J Endourol"},{"key":"1829_CR8","doi-asserted-by":"publisher","first-page":"e7039","DOI":"10.1097\/MD.0000000000007039","volume":"96","author":"HJ Meyer","year":"2017","unstructured":"Meyer HJ, Pfeil A, Schramm D, Bach AG, Surov A (2017) Renal incidental findings on computed tomography: frequency and distribution in a large non selected cohort. Medicine (Baltimore) 96:e7039. https:\/\/doi.org\/10.1097\/MD.0000000000007039","journal-title":"Medicine (Baltimore)"},{"key":"1829_CR9","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.juro.2008.01.097","volume":"179","author":"MR Cooperberg","year":"2008","unstructured":"Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ (2008) Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol 179:2131\u20132135. https:\/\/doi.org\/10.1016\/j.juro.2008.01.097","journal-title":"J Urol"},{"key":"1829_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/jnci\/djj362","volume":"98","author":"JM Hollingsworth","year":"2006","unstructured":"Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331\u20131334. https:\/\/doi.org\/10.1093\/jnci\/djj362","journal-title":"J Natl Cancer Inst"},{"key":"1829_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2020.06.053","volume":"78","author":"A Finelli","year":"2020","unstructured":"Finelli A, Cheung DC, Al-Matar A et al (2020) Small renal mass surveillance: histology-specific growth rates in a biopsy-characterized cohort. Eur Urol 78:460\u2013467. https:\/\/doi.org\/10.1016\/j.eururo.2020.06.053","journal-title":"Eur Urol"},{"key":"1829_CR12","doi-asserted-by":"publisher","first-page":"79.e1","DOI":"10.1016\/j.urolonc.2020.10.015","volume":"39","author":"DN Patel","year":"2021","unstructured":"Patel DN, Ghali F, Meagher MF et al (2021) Utilization of renal mass biopsy in patients with localized renal cell carcinoma: a population-based study utilizing the National Cancer Database. Urol Oncol 39:79.e1\u201379.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2020.10.015","journal-title":"Urol Oncol"},{"key":"1829_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiol.2021204227","volume":"302","author":"N Schieda","year":"2021","unstructured":"Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG (2021) Active surveillance of renal masses: the role of radiology. Radiology 302:11\u201324. https:\/\/doi.org\/10.1148\/radiol.2021204227","journal-title":"Radiology"},{"key":"1829_CR14","doi-asserted-by":"publisher","first-page":"e220209","DOI":"10.1148\/rg.220209","volume":"43","author":"AS Shetty","year":"2023","unstructured":"Shetty AS, Fraum TJ, Ballard DH et al (2023) Renal mass imaging with MRI clear cell likelihood score: a user\u2019s guide. Radiographics 43:e220209. https:\/\/doi.org\/10.1148\/rg.220209","journal-title":"Radiographics"},{"key":"1829_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1148\/radiol.210034","volume":"302","author":"I Pedrosa","year":"2022","unstructured":"Pedrosa I, Cadeddu JA (2022) How we do it: managing the indeterminate renal mass with the MRI clear cell likelihood score. Radiology 302:256\u2013269. https:\/\/doi.org\/10.1148\/radiol.210034","journal-title":"Radiology"},{"key":"1829_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230042","volume":"43","author":"I Pedrosa","year":"2023","unstructured":"Pedrosa I (2023) MRI clear cell likelihood score for indeterminate solid renal masses: is there a path for broad clinical adoption? Radiographics 43:e230042. https:\/\/doi.org\/10.1148\/rg.230042","journal-title":"Radiographics"},{"key":"1829_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1148\/radiol.2018171557","volume":"287","author":"FU Kay","year":"2018","unstructured":"Kay FU, Canvasser NE, Xi Y et al (2018) Diagnostic performance and interreader agreement of a standardized MR imaging approach in the prediction of small renal mass histology. Radiology 287:543\u2013553. https:\/\/doi.org\/10.1148\/radiol.2018171557","journal-title":"Radiology"},{"key":"1829_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1004502","volume":"12","author":"J Tian","year":"2022","unstructured":"Tian J, Teng F, Xu H, Zhang D, Chi Y, Zhang H (2022) Systematic review and meta-analysis of multiparametric MRI clear cell likelihood scores for classification of small renal masses. Front Oncol 12:1004502. https:\/\/doi.org\/10.3389\/fonc.2022.1004502","journal-title":"Front Oncol"},{"key":"1829_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.juro.2017.04.089","volume":"198","author":"NE Canvasser","year":"2017","unstructured":"Canvasser NE, Kay FU, Xi Y et al (2017) Diagnostic accuracy of multiparametric magnetic resonance imaging to identify clear cell renal cell carcinoma in cT1a renal masses. J Urol 198:780\u2013786. https:\/\/doi.org\/10.1016\/j.juro.2017.04.089","journal-title":"J Urol"},{"key":"1829_CR20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.urolonc.2019.07.023","volume":"7","author":"BA Johnson","year":"2019","unstructured":"Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA (2019) Diagnostic performance of prospectively assigned clear cell likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 7:941\u2013946. https:\/\/doi.org\/10.1016\/j.urolonc.2019.07.023","journal-title":"Urol Oncol"},{"key":"1829_CR21","doi-asserted-by":"publisher","first-page":"e874","DOI":"10.1097\/JU.0000000000002075.02","volume":"206","author":"T Morgan","year":"2021","unstructured":"Morgan T, Dai J, Kommidi V, Kusin S, Pedrosa I, Cadeddu J (2021) Mp49-02 clear cell likelihood scores (ccLS) on multiparametric MRI decreases benign pathology rates in patients with chronic kidney disease (CKD) being considered for extirpative nephron sparing surgery (NSS). J Urol 206:e874\u2013e875. https:\/\/doi.org\/10.1097\/JU.0000000000002075.02","journal-title":"J Urol"},{"key":"1829_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2214\/AJR.22.27378","volume":"219","author":"M Dunn","year":"2022","unstructured":"Dunn M, Linehan V, Clarke SE, Keough V, Nelson R, Costa AF (2022) Diagnostic performance and interreader agreement of the mri clear cell likelihood score for characterization of cT1a and cT1b solid renal masses: an external validation study. AJR Am J Roentgenol 219:793\u2013803. https:\/\/doi.org\/10.2214\/AJR.22.27378","journal-title":"AJR Am J Roentgenol"},{"key":"1829_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.211680","volume":"303","author":"N Schieda","year":"2022","unstructured":"Schieda N, Davenport MS, Silverman SG et al (2022) multicenter evaluation of multiparametric MRI clear cell likelihood scores in solid indeterminate small renal masses. Radiology 303:590\u2013599. https:\/\/doi.org\/10.1148\/radiol.211680","journal-title":"Radiology"},{"key":"1829_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3760\/cma.j.cn112149-20221105-00889","volume":"57","author":"Y Hao","year":"2023","unstructured":"Hao Y, Guo H, Wang H et al (2023) Interobserver agreement and diagnostic performance assessment of clear cell likelihood score using T2WI with fat suppression technique. Chin J Radiol 57:528\u2013534. https:\/\/doi.org\/10.3760\/cma.j.cn112149-20221105-00889","journal-title":"Chin J Radiol"},{"key":"1829_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.12122\/j.issn.1673-4254.2023.05.16","volume":"43","author":"Y Hao","year":"2023","unstructured":"Hao Y, Gao S, Zhang X et al (2023) Comparison of diagnostic performance of clear cell likelihood score v1.0 and v2.0 for clear renal cell carcinoma. J South Med Univ 43:800\u2013806. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2023.05.16","journal-title":"J South Med Univ"},{"key":"1829_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00261-023-03799-z","volume":"48","author":"A Ibrahim","year":"2023","unstructured":"Ibrahim A, Pelsser V, Anidjar M, Kaitoukov Y, Camlioglu E, Moosavi B (2023) Performance of clear cell likelihood scores in characterizing solid renal masses at multiparametric MRI: an external validation study. Abdom Radiol (NY) 48:1033\u20131043. https:\/\/doi.org\/10.1007\/s00261-023-03799-z","journal-title":"Abdom Radiol (NY)"},{"key":"1829_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2214\/AJR.22.27971","volume":"219","author":"K Al Nasibi","year":"2022","unstructured":"Al Nasibi K, Pickovsky JS, Eldehimi F et al (2022) Development of a multiparametric renal CT algorithm for diagnosis of clear cell renal cell carcinoma among small (\u2264 4 cm) solid renal masses. AJR Am J Roentgenol 219:814\u2013823. https:\/\/doi.org\/10.2214\/AJR.22.27971","journal-title":"AJR Am J Roentgenol"},{"key":"1829_CR28","doi-asserted-by":"publisher","unstructured":"Eldihimi F, Walsh C, Hibbert RM, Nasibi KA, Pickovsky JS, Schieda N (2024) Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (\u2264\u20094 cm) solid renal masses. Eur Radiol 34:3992\u20134000. https:\/\/doi.org\/10.1007\/s00330-023-10434-4","DOI":"10.1007\/s00330-023-10434-4"},{"key":"1829_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2214\/AJR.23.29151","volume":"221","author":"S Lemieux","year":"2023","unstructured":"Lemieux S, Shen L, Liang T et al (2023) External validation of a five-tiered CT algorithm for the diagnosis of clear cell renal cell carcinoma: a retrospective five-reader study. AJR Am J Roentgenol 221:334\u2013343. https:\/\/doi.org\/10.2214\/AJR.23.29151","journal-title":"AJR Am J Roentgenol"},{"key":"1829_CR30","doi-asserted-by":"publisher","first-page":"i3507","DOI":"10.1136\/bmj.i3507","volume":"354","author":"P Garner","year":"2016","unstructured":"Garner P, Hopewell S, Chandler J et al (2016) When and how to update systematic reviews: consensus and checklist. BMJ 354:i3507. https:\/\/doi.org\/10.1136\/bmj.i3507","journal-title":"BMJ"},{"key":"1829_CR31","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1829_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-019-1090-9","volume":"8","author":"TA McGrath","year":"2019","unstructured":"McGrath TA, Moher D, McInnes MDF (2019) Steps toward more complete reporting of systematic reviews of diagnostic test accuracy: preferred reporting items for systematic reviews and meta-analyses of diagnostic test accuracy (PRISMA-DTA). Syst Rev 8:166. https:\/\/doi.org\/10.1186\/s13643-019-1090-9","journal-title":"Syst Rev"},{"key":"1829_CR33","doi-asserted-by":"publisher","unstructured":"Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https:\/\/doi.org\/10.1186\/2046-4053-4-1","DOI":"10.1186\/2046-4053-4-1"},{"key":"1829_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z","volume":"10","author":"ML Rethlefsen","year":"2021","unstructured":"Rethlefsen ML, Kirtley S, Waffenschmidt S et al (2021) PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev 10:39. https:\/\/doi.org\/10.1186\/s13643-020-01542-z","journal-title":"Syst Rev"},{"key":"1829_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"1829_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0724-x","volume":"19","author":"SC Freeman","year":"2019","unstructured":"Freeman SC, Kerby CR, Patel A, Cooper NJ, Quinn T, Sutton AJ (2019) Development of an interactive web-based tool to conduct and interrogate meta-analysis of diagnostic test accuracy studies: MetaDTA. BMC Med Res Methodol 19:81. https:\/\/doi.org\/10.1186\/s12874-019-0724-x","journal-title":"BMC Med Res Methodol"},{"key":"1829_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jrsm.1439","volume":"12","author":"A Patel","year":"2021","unstructured":"Patel A, Cooper N, Freeman S, Sutton A (2021) Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta-analysis of diagnostic test accuracy data. Res Synth Methods 12:34\u201344. https:\/\/doi.org\/10.1002\/jrsm.1439","journal-title":"Res Synth Methods"},{"key":"1829_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","volume":"21","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Radua J (2018) Ten simple rules for conducting umbrella reviews. Evid Based Ment Health 21:95\u2013100. https:\/\/doi.org\/10.1136\/ebmental-2018-300014","journal-title":"Evid Based Ment Health"},{"key":"1829_CR39","doi-asserted-by":"publisher","first-page":"e300534","DOI":"10.1136\/bmjment-2022-300534","volume":"26","author":"CJ Gosling","year":"2023","unstructured":"Gosling CJ, Solanes A, Fusar-Poli P, Radua J (2023) metaumbrella: the first comprehensive suite to perform data analysis in umbrella reviews with stratification of the evidence. BMJ Ment Health 26:e300534. https:\/\/doi.org\/10.1136\/bmjment-2022-300534","journal-title":"BMJ Ment Health"},{"key":"1829_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00330-020-07093-0","volume":"31","author":"RL Steinberg","year":"2021","unstructured":"Steinberg RL, Rasmussen RG, Johnson BA et al (2021) Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol 31:314\u2013324. https:\/\/doi.org\/10.1007\/s00330-020-07093-0","journal-title":"Eur Radiol"},{"key":"1829_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.eururo.2007.11.023","volume":"53","author":"K Bensalah","year":"2008","unstructured":"Bensalah K, Cr\u00e9pel M, Patard JJ (2008) Tumor size and nephron-sparing surgery: does it still matter? Eur Urol 53:691\u2013693. https:\/\/doi.org\/10.1016\/j.eururo.2007.11.023","journal-title":"Eur Urol"},{"key":"1829_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2007.01.039","volume":"52","author":"JJ Patard","year":"2007","unstructured":"Patard JJ, Pantuck AJ, Crepel M et al (2007) Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol 52:148\u2013154. https:\/\/doi.org\/10.1016\/j.eururo.2007.01.039","journal-title":"Eur Urol"},{"key":"1829_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/s0022-5347(17)41026-3","volume":"141","author":"AC Novick","year":"1989","unstructured":"Novick AC, Streem S, Montie JE et al (1989) Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 141:835\u2013839. https:\/\/doi.org\/10.1016\/s0022-5347(17)41026-3","journal-title":"J Urol"},{"key":"1829_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejrad.2010.11.012","volume":"81","author":"AB Rosenkrantz","year":"2012","unstructured":"Rosenkrantz AB, Raj S, Babb JS, Chandarana H (2012) Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma. Eur J Radiol 81:47\u201351. https:\/\/doi.org\/10.1016\/j.ejrad.2010.11.012","journal-title":"Eur J Radiol"},{"key":"1829_CR45","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00330-015-3981-z","volume":"26","author":"M Ge","year":"2016","unstructured":"Ge M, Zhang J, Wu B (2016) Effect of gadolinium on hepatic fat quantification using multi-echo reconstruction technique with T2* correction and estimation. Eur Radiol 26:1913\u20131920. https:\/\/doi.org\/10.1007\/s00330-015-3981-z","journal-title":"Eur Radiol"},{"key":"1829_CR46","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00330-017-4988-4","volume":"28","author":"RS Lim","year":"2018","unstructured":"Lim RS, Flood TA, McInnes MDF, Lavallee LT, Schieda N (2018) Renal angiomyolipoma without visible fat: can we make the diagnosis using CT and MRI? Eur Radiol 28:542\u2013553. https:\/\/doi.org\/10.1007\/s00330-017-4988-4","journal-title":"Eur Radiol"},{"key":"1829_CR47","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1007\/s00261-023-04034-5","volume":"48","author":"YW Hao","year":"2023","unstructured":"Hao YW, Zhang Y, Guo HP et al (2023) Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score. Abdom Radiol (NY) 48:3714\u20133727. https:\/\/doi.org\/10.1007\/s00261-023-04034-5","journal-title":"Abdom Radiol (NY)"},{"key":"1829_CR48","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.3760\/cma.j.cn112137-20221020-02193","volume":"102","author":"MQ Cui","year":"2022","unstructured":"Cui MQ, He B, Xu W et al (2022) Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma. Natl Med J China 102:3779\u20133785. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20221020-02193","journal-title":"Natl Med J China"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01829-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01829-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01829-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:02:40Z","timestamp":1728478960000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01829-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01829-y","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.Y.Z. acknowledges his position as a member of the Scientific Editorial Board of <i>European Radiology<\/i> and <i>BMC Medical Imaging<\/i>. He has, therefore, not taken part in the review or selection process of this paper. Y.S. and M.D.L. from a commercial company, Siemens Healthineers Ltd., are MR collaboration scientists and technicians doing technical support under Siemens collaboration regulation without any payment and personal concern regarding this study. All other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}